Quotation request for + securities
Summary of the announcement
Name of entity
LIMITED BIOSCIENCE RHYTHM
Type of news
New Listing
Date of this announcement
Thursday 02 December 2021
The + securities to be listed are:
+ Securities issued, transferred or reclassified following the exercise of options or other + convertible securities being converted
Total number of + securities to be listed
ASX + security |
Number of + titles to |
||
coded |
Security Description |
to be quoted |
Date of issue |
RHY |
REGULAR FULLY PAID |
1,768 |
12/02/2021 |
See the next page for details on the announcement
Quotation request for + securities |
1/7 |
Quotation request for + securities
Part 1 – Entity and Listing Details
1.1 Entity name
LIMITED BIOSCIENCE RHYTHM
We (the entity named above) request + a listing of the following + securities and accept the questions set out in Appendix 2A of the ASX Listing Rules.
1.2 |
Registered number type |
Registration number |
ABN |
59619459335 |
|
1.3 |
ASX transmitter code |
|
RHY |
- The announcement is New Listing
- Date of this announcement
2/12/2021
Quotation request for + securities |
2/7 |
Quotation request for + securities
Part 2 – Type of problem
2.1 The + securities to be listed are:
+ Securities issued, transferred or reclassified following the exercise of options or other + convertible securities being converted
2.2 The + securities to be listed are:
Additional + titles in a class already listed on the ASX (“existing class”)
Quotation request for + securities |
3/7 |
Quotation request for + securities
Part 3B – number and type of + listed securities (existing category) the issue of which has not been previously notified to the ASX in an appendix 3B
+ existing titles converted into + additional titles in an existing class
DE (existing class)
ASX + security code and description
RHYAK: OPTION EXPIRING 31-AOT-2022 EX $ 1.20
To (existing class)
ASX + security code and description
RHY: ORDINARY FULLY PAID
Please indicate the number of options that have been exercised or other + convertible securities that have been converted
1,028
The first date on which the options were exercised or the other convertible + securities were converted
2/12/2021
The last date of exercise of options or conversion of other + convertible securities
2/12/2021
Are these all options or other convertible + securities issued on issue of this type (i.e. have all these options been exercised or have all these convertible securities now been converted)?
No
The right of the holder of options or other convertible + securities to receive the + underlying securities is satisfied by:
A show of new + titles
The underlying securities received by the holder are:
Intended to be, but not yet, cited by ASX
Have the options been exercised or have other convertible securities been converted as part of an employee profit-sharing plan?
No
Date of issue
2/12/2021
Will the + securities to be listed rank in all respects from their date of issue as the + existing securities issued in this category?
Yes
Quotation request for + securities |
4/7 |
Quotation request for + securities
Details of the problem
Number of + securities to be listed
1,028
Are + securities issued for cash consideration?
Yes
In what currency is the cash consideration paid? What is the issue price per + security?
AUD – Australian Dollar |
1.20000000 AUD |
Any other information that the entity wishes to provide on the + securities to be listed
+ existing titles converted into + additional titles in an existing class
DE (existing class)
ASX + security code and description
RHYAL: OPTION EXPIRING JUL 31, 2024 $ 1.80
To (existing class)
ASX + security code and description
RHY: ORDINARY FULLY PAID
Please indicate the number of options that have been exercised or other + convertible securities that have been converted
740
The first date on which the options were exercised or the other convertible + securities were converted
2/12/2021
The last date of exercise of options or conversion of other + convertible securities
2/12/2021
Are these all options or other convertible + securities issued on issue of this type (i.e. have all these options been exercised or have all these convertible securities now been converted)?
No
The right of the holder of options or other convertible + securities to receive the + underlying securities is satisfied by:
A show of new + titles
The underlying securities received by the holder are:
Intended to be, but not yet, cited by ASX
Have the options been exercised or have other convertible securities been converted as part of an employee profit-sharing plan?
No
Quotation request for + securities |
5/7 |
This is an excerpt from the original content. To continue reading it, access the original document here.
Disclaimer
Rhythm Biosciences Ltd. published this content on 02 December 2021 and is solely responsible for the information it contains. Distributed by Public, unedited and unmodified, on 02 December 2021 05:30:07 AM UTC.
Public now 2021
|
|
|
|
|
||||
|
||||
Technical analysis trends RHYTHM BIOSCIENCES LIMITED
Short term | Mid Road | Long term | |
Tendencies | Neutral | Bullish | Bullish |
Evolution of the income statement
To sell ![]() To buy |
|
Average consensus | TO BUY |
Number of analysts | 0 |
Last closing price |
1.74 |
Average price target | |
Spread / Average target |
– |